This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agnello, D.
Right arrow Articles by Pothier, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agnello, D.
Right arrow Articles by Pothier, P.

 Previous Article  |  Next Article 

Journal of Virology, April 2006, p. 3823-3832, Vol. 80, No. 8
0022-538X/06/$08.00+0     doi:10.1128/JVI.80.8.3823-3832.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Intrarectal Immunization with Rotavirus 2/6 Virus-Like Particles Induces an Antirotavirus Immune Response Localized in the Intestinal Mucosa and Protects against Rotavirus Infection in Mice{ddagger}

Davide Agnello,1,{dagger}* Christine A. Hervé,1,{dagger} Amandine Lavaux,1 Magali Darniot,1 Patrice Guillon,1 Annie Charpilienne,2 and Pierre Pothier1

Laboratoire de Virologie et Centre National de Référence des Virus Entériques, Faculté de Médecine, Université de Bourgogne, Dijon,1 Laboratoire de Virologie Moléculaire et Structurale, UMR INRA-CNRS, Gif-sur-Yvette, France2

Received 18 August 2005/ Accepted 31 January 2006

Rotavirus (RV) is the main etiological agent of severe gastroenteritis in infants, and vaccination seems the most effective way to control the disease. Recombinant rotavirus-like particles composed of the viral protein 6 (VP6) and VP2 (2/6-VLPs) have been reported to induce protective immunity in mice when administered by the intranasal (i.n.) route. In this study, we show that administration of 2/6-VLPs by the intrarectal (i.r.) route together with either cholera toxin (CT) or a CpG-containing oligodeoxynucleotide as the adjuvant protects adult mice against RV infection. Moreover, when CT is used, RV shedding in animals immunized by the i.r. route is even reduced in comparison with that in animals immunized by the i.n. route. Humoral and cellular immune responses induced by these immunization protocols were analyzed. We found that although i.r. immunization with 2/6-VLPs induces lower RV-specific immunoglobulin G (IgG) and IgA levels in serum, intestinal anti-RV IgA production is higher in mice immunized by the i.r. route. Cellular immune response has been evaluated by measuring cytokine production by spleen and Peyer's patch cells (PPs) after ex vivo restimulation with RV. Mice immunized by the i.n. and i.r. routes display higher gamma interferon production in spleen and PPs, respectively. In conclusion, we demonstrate that i.r. immunization with 2/6-VLPs protects against RV infection in mice and is more efficient than i.n. immunization in inducing an anti-RV immune response in intestinal mucosa.


* Corresponding author. Mailing address: Laboratoire de Virologie, CHU et Faculté de Médecine, Université de Bourgogne, 7 boulevard Jeanne d'Arc, 21079 Dijon Cedex, France. Phone: 33 (0)3 80 29 31 71. Fax: 33 (0)3 80 29 36 04. E-mail: Davide.Agnello{at}u-bourgogne.fr.

{ddagger} This work is dedicated to the memory of Dr. Jean Cohen (deceased November 2004).

{dagger} These authors equally contributed to this work.


Journal of Virology, April 2006, p. 3823-3832, Vol. 80, No. 8
0022-538X/06/$08.00+0     doi:10.1128/JVI.80.8.3823-3832.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Belyakov, I. M., Ahlers, J. D. (2009). What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?. J. Immunol. 183: 6883-6892 [Abstract] [Full Text]  
  • Kim-Schulze, S., Kim, H. S., Wainstein, A., Kim, D. W., Yang, W. C., Moroziewicz, D., Mong, P. Y., Bereta, M., Taback, B., Wang, Q., Kaufman, H. L. (2008). Intrarectal Vaccination with Recombinant Vaccinia Virus Expressing Carcinoembronic Antigen Induces Mucosal and Systemic Immunity and Prevents Progression of Colorectal Cancer. J. Immunol. 181: 8112-8119 [Abstract] [Full Text]  
  • Jiang, J. Q., He, X.-S., Feng, N., Greenberg, H. B. (2008). Qualitative and Quantitative Characteristics of Rotavirus-Specific CD8 T Cells Vary Depending on the Route of Infection. J. Virol. 82: 6812-6819 [Abstract] [Full Text]  
  • Di Martino, C., Basset, C., Ogier, A., Charpilienne, A., Poncet, D., Kohli, E. (2007). Distribution and phenotype of rotavirus-specific B cells induced during the antigen-driven primary response to 2/6 virus-like particles administered by the intrarectal and the intranasal routes. J. Leukoc. Biol. 82: 821-828 [Abstract] [Full Text]